Program schedule

(all times are ET)

register today button

Wednesday, Oct. 27

10 - 10:50am: Welcome from ARVO President & Opening Keynote, Why Does Health Economics and Outcomes Research (HEOR) Matter?
Maureen G. Maguire, PhD, FARVODennis P. Scanlon, PhD  
Dennis Scanlon, Distinguished Professor of Health Policy & Administration and Director, Center for Health Care Policy Research at PennState College of Health and Human Development, will answer the question, Why Does Health Economics and Outcomes Research (HEOR) Matter? He will highlight a variety of the benefits for patients and scientists and illustrate how cost-effectiveness and outcomes measurement has been applied in ways that serve specific audiences (government, manufacturers, payers) and could be applied in future research projects.  

11am - 12:20pm: Fundamentals of patient reported outcomes research 
Bonnielin K Swenor, MPH, PhDVijaya Gothwal, PhDDavid C Musch, PhD, MPH, FARVOJoão Pedro Marques, MD, MSc, FEBO, Jyoti Khadka, PhDKonrad Pesudovs, PhD
Patient reported outcome (PROs) measures and measurement instruments vary depending on the ophthalmic condition, so it is important to select the most effective option for your research question. Investigators should also consider linguistic variations among the patients being studied when designing measurement tools. The speakers in this session will explain the science of PRO measurement (PROM) highlighting best practices and including how to define what you want to measure, select the appropriate PRO measure and measurement tool appropriate for the ophthalmic condition and ensure your measurement instrument is accessible to a diverse patient population. The session will end with a discussion of the intersection of PROMs and HEOR. Bring your questions for the interactive Q&A. 

12:30 - 2pm: Fundamentals of HEOR
Andrew F. Smith, BA, MSc., PhDKevin D. Frick, PhDAlison Abraham, PhD
What are the main forms of economic evaluation in healthcare? How does one identify, measure and value costs; quantify and value benefits; select the appropriate health economic evaluation tool and/or technique; and/or critically appraise the health economic evaluations in the literature? What are useful data sources for health economics analyses in specific countries? The speakers in this session will share their answers to these questions. Bring your questions for the interactive Q&A.

This session ends with a synthesis of the day’s topics and a preview of Day 2.


Thursday, Oct. 28

10 - 10:50am: Formulating HEOR questions panel discussion
Kevin D. Frick, PhDDavid B. Rein, Ph.D.Lisa Keay, PhD, MPH, B (Optom)Tasanee Braithwaite, BMBCh, MPH, DM
The panelists in the session will introduce various methodologies for formulating HEOR research questions highlighting how the examples to be presented today employed them. 

11am - 12:20pm: Concurrent 1: HEOR case studies
David B. Rein Ph.D.Melissa BrownEcosse Lamoureux, MSc, PhDMarilyn JamesThomas Arno Albini, MDAndrew F. Smith, BA, MSc., PhD
Discover how investigators evaluated the economic burden of vision loss and blindness and non-infectious inflammatory eye disease (NIIED) in the United States. Learn the similarities and differences when assessing the health economics of diabetic retinopathy screening in Singapore versus in the United Kingdom and more.  

11am - 12:20pm: Concurrent 2: Patient reported outcomes research case studies 
Ian SaldanhaHimal Kandel, PhD; MSc PHECJoshua R Ehrlich, MD, MPH Maria Fernanda Abalem, MD, MSc, PhDTasanee Braithwaite, BMBCh, MPH, DMKonrad Pesudovs, PhD
Hear about patient reported outcomes related to dry eye, corneal cross-linking for keratoconus and older adults with vision impairment. Explore the development of PROs recently used in clinical trials for retinal dystrophies and the inclusion of PROMs and estimating utility in epidemiological surveys during the National Eye Survey of Trinidad and Tobago.  

12:30 - 1:15pm: Panel discussion: Industry perspectives on HEOR
Andrew F. Smith, BA, MSc., PhDJulio BenedictoH. Nida Sen, MDMichelle Senchyna, PhDEric Nelson
Representatives from Gensight Biologics, Janssen Retina, Aerie Pharmaceuticals and an independent consulting firm, NCEBiotech LLC, come together to review the dynamics and type of data required to help ophthalmic drugs and devices enter the global marketplace.  

1:25 - 2:15pm: Panel discussion: Regulatory perspectives on HEOR 
Tieuvi Nguyen, PhD, Sarah Norris, PhDFraser BocellMitchell Levine, Christopher McCabeKevin D. Frick, PhD and Andrew F. Smith, BA, MSc, PhD
Exploring HEOR questions can be more impactful when the answers provide data that matter to government agencies and regulators. Representatives from the U.S. FDA, Ophthalmic Devices Division, the Patented Medicine Prices Review Board of Canada, and the Pharmaceutical Benefits Scheme (PBS) of Australia will talk about the data examined by their agencies.

This session ends with a synthesis of the day’s topics and a preview of Day 3. 


Friday, Oct. 29

10 - 10:50am: Closing Keynote
Rachel Dungan, M.S.S.P.
Rachel Dungan, Director, AcademyHealth, will share her experiences supporting the advancement of health policy and systems research (HPSR), plus the enhancement of its impact. She will talk about her work studying the effective and ethical engagement of diverse stakeholders in health research activities, applying human-centered design approaches to develop and test disruptive innovations, bolstering the patient-centered outcomes research (PCOR) data infrastructure on behalf of the Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation (ASPE) and her collaboration with the Patient-Centered Outcomes Research Institute (PCORI) for an ongoing investigation of the literature on the engagement of patients, communities and stakeholders throughout research design and implementation processes. Dungan will also discuss her personal experience as a keratoconus patient and how it led her to become an advocate for vision research. 

11 - 11:55am: Keeping the patients in mind when designing experiments
Helen Baker, PhDOrla Galvin, BSc, PhDPenny Asbell, MD, FACS, MBA, FARVOEmily Patterson, PhD
Patient-centered approaches and early patient involvement in project planning are important in outcomes research. Explore the impact of engaging the patient with real-world scenarios. Learn how to collate, analyze and report patients’ views, plus how to involve patients in the research design process.  

  • Penny Asbell: DREAMing about Patients First
  • Helen Baker: Why patient-centered approaches and early patient involvement in project planning is important in outcomes research
  • Orla Galvin: Health economics and the patient

Noon - 1pm: Ask the experts: Applying the concepts to your research project 
Kevin D. Frick, PhDAndrew F. Smith, BA, MSc., PhDLisa Keay, PhD, MPH, B (Optom)Helen Baker, PhDPenny Asbell, MD, FACS, MBA, FARVO
Can’t miss this session. Conference planners, speakers and panelists will be available to answer questions specific to attendees’ research projects. Leave this session with concrete advice to implement now.

This session ends with closing remarks from the conference organizers.

* This program is subject to change. 

View the speaker lineup for the Health Economics and Outcomes Research Conference
Health Economics and Outcomes Planning Committee
Meet the experts who put the conference together
CME information
CME disclosures and instructions for claiming credit